All Type of News
Drug wholesalers to face margin cut
Some pharmaceutical firms' movement to slash a small percentage of wholesaler margin may cast a shadow over the wholesaler's overall management, according to pharmaceutical sources.
In fact, the local pharmaceutica...
Groundless bankruptcy speculation haunts drug wholesalers
Ceaseless rumors have spread that some drug wholesalers face bankruptcy as the year-end is now approaching, perplexing the entire wholesaling industry, according to sources.
The groundless bankruptcy issues have we...
Restricted healthcare coverage for minor disease planned
The government plans to restrict the benefits of healthcare over widely used over-the-counter drugs or medical plasters to treat minor disease as self-medication usage, possible in the first quarter of next year, acco...
Dong-A's Zydena grabs bigger market share
Dong-A Pharm is expanding its share of the domestic anti-impotence drug market dominated by international drug makers.
Zydena, the first-domestically-made medication for erectile dysfunction, is challenging Viagra...
Cut-throat competition lowers prices of renowned cold remedies
The prices of such renowned cold medicines as Hituben, Hwacol and Haben were reduced to 1,200 won from 1,600 won due to more heated competition among drug makers, according to market sources.
The sources say that b...
Choong-wae Medical to break ground for new medical device plantA ground-breaking ceremony for construction of a new medical device plant was held in Choongju, Chungcheong Province on November 29.
Company officials, including Choong-wae H...
|
Dong-A gearing up to sharpen brand powerDong-A Pharm is flexing its muscles to go global with its flagship products such as anti-ulcerant Stillen and anti-impotence medicine Zydena.
Dong-A cerebrated its 75th found...
|
5 government agencies to be relocated in 2010The five health-related government agencies the Korea Food and Drug Administration, the Korea Centers for Disease Control and Prevention, the National Institute of Toxicologica...
|
Janssen Korea and J&J Korea to seek co-marketing from next year
Janssen Korea and Johnson & Johnson Korea has announced that they would co-market Tylenol (acetaminophen) and Nizoral (ketoconazole) in the domestic market from January 1, next year, as part of efforts to maximize ind...
Green Cross, Abraxis BioScience enter cross licensing agreementGreen Cross Corporation and U.S.-based Abraxis BioScience Inc, an integrated and global biopharmaceutical company, announced on November 27 an agreement for the development and ...
|
